Lee Youngkyun, Haas Karen M, Gor Dennis O, Ding Xuedong, Karp David R, Greenspan Neil S, Poe Jonathan C, Tedder Thomas F
Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.
J Immunol. 2005 Dec 15;175(12):8011-23. doi: 10.4049/jimmunol.175.12.8011.
C3d can function as a molecular adjuvant by binding CD21 and thereby enhancing B cell activation and humoral immune responses. However, recent studies suggest both positive and negative roles for C3d and the CD19/CD21 signaling complex in regulating humoral immunity. To address whether signaling through the CD19/CD21 complex can negatively regulate B cell function when engaged by physiological ligands, diphtheria toxin (DT)-C3d fusion protein and C3dg-streptavidin (SA) complexes were used to assess the role of CD21 during BCR-induced activation and in vivo immune responses. Immunization of mice with DT-C3d3 significantly reduced DT-specific Ab responses independently of CD21 expression or signaling. By contrast, SA-C3dg tetramers dramatically enhanced anti-SA responses when used at low doses, whereas 10-fold higher doses did not augment immune responses, except in CD21/35-deficient mice. Likewise, SA-C3dg (1 microg/ml) dramatically enhanced BCR-induced intracellular calcium concentration ([Ca2+]i) responses in vitro, but had no effect or inhibited [Ca2+]i responses when used at 10- to 50-fold higher concentrations. SA-C3dg enhancement of BCR-induced [Ca2+]i responses required CD21 and CD19 expression and resulted in significantly enhanced CD19 and Lyn phosphorylation, with enhanced Lyn/CD19 associations. BCR-induced CD22 phosphorylation and Src homology 2 domain-containing protein tyrosine phosphatase-1/CD22 associations were also reduced, suggesting abrogation of negative regulatory signaling. By contrast, CD19/CD21 ligation using higher concentrations of SA-C3dg significantly inhibited BCR-induced [Ca2+]i responses and inhibited CD19, Lyn, CD22, and Syk phosphorylation. Therefore, C3d may enhance or inhibit Ag-specific humoral immune responses through both CD21-dependent and -independent mechanisms depending on the concentration and nature of the Ag-C3d complexes.
C3d可通过结合CD21发挥分子佐剂的作用,从而增强B细胞活化和体液免疫反应。然而,最近的研究表明C3d和CD19/CD21信号复合物在调节体液免疫中具有正向和负向作用。为了探讨当与生理性配体结合时,通过CD19/CD21复合物的信号传导是否会对B细胞功能产生负调节作用,使用白喉毒素(DT)-C3d融合蛋白和C3dg-链霉亲和素(SA)复合物来评估CD21在BCR诱导的活化和体内免疫反应中的作用。用DT-C3d3免疫小鼠可显著降低DT特异性抗体反应,且与CD21表达或信号传导无关。相比之下,低剂量使用SA-C3dg四聚体可显著增强抗SA反应,而高10倍的剂量除了在CD21/35缺陷小鼠中外,并未增强免疫反应。同样,SA-C3dg(1微克/毫升)在体外可显著增强BCR诱导的细胞内钙浓度([Ca2+]i)反应,但当使用高10至50倍的浓度时则无作用或抑制[Ca2+]i反应。SA-C3dg增强BCR诱导的[Ca2+]i反应需要CD21和CD19表达,并导致CD19和Lyn磷酸化显著增强,同时Lyn/CD19结合增强。BCR诱导的CD22磷酸化以及含Src同源2结构域的蛋白酪氨酸磷酸酶-1/CD22结合也减少,表明负调节信号被消除。相比之下,使用更高浓度的SA-C3dg进行CD19/CD21连接可显著抑制BCR诱导的[Ca2+]i反应,并抑制CD19、Lyn、CD22和Syk磷酸化。因此,根据Ag-C3d复合物的浓度和性质,C3d可能通过依赖和不依赖CD21的机制增强或抑制抗原特异性体液免疫反应。